Astellas Announces New Recovery Plan

Observers have welcomed a new five-year plan announced by third-ranked Japanese drugmaker Astellas. However, despite the warm reception, the announcements contain little to dispel suspicions that the company faces short-term decline and is now a potential takeover target.

To read the full article, please choose one of the following options: